Cargill helps Enough with its goal to grow over one million tons of Abunda mycoprotein cumulatively by 2033, as they partner to innovate sustainable alternative meat solutions. The collaboration entails Cargill investing in Enough’s growth funding campaign and engaging in a commercial agreement to market its fermented protein. This partnership aims to address the global demand for sustainable protein production. By leveraging each other’s expertise, resources, and technologies, Cargill and Enough strive to make a significant impact in the alternative protein market.
Enough’s Abunda mycoprotein is cultivated using a pioneering fermentation technology that utilizes sustainably sourced grain and Cargill’s glucose syrup as key ingredients. The zero-waste fermentation process results in a complete food ingredient rich in essential amino acids and dietary fiber. Cargill’s commitment to sustainability aligns with Enough’s vision of scaling up production while meeting the nutritional needs of an evolving consumer base. Through this enhanced partnership, the companies are poised to introduce new alternative protein products to the market, leveraging Cargill’s expansive network and expertise in food solutions.
With a global focus on nourishing the world responsibly, Cargill sees the potential of mycoprotein as a sustainable and scalable protein source. The collaboration with Enough underscores Cargill’s dedication to providing diverse protein options that prioritize health, sustainability, and innovation. As the alternative protein market continues to expand, Cargill and Enough are well-positioned to lead the way in developing impactful solutions for a more sustainable food future.
